Valiant Organics Q2 FY27 Share Price & Earnings Call Analysis

₹348.20+0.72% today
Market cap
₹976 Cr
P/E
17.46
ROE
4.00%
PEG
-0.63
Price to sales
1.07
Debt to equity
0.33
52W high / low
₹497 / ₹198
Sales growth (5Y)
5.16%
EBITDA margin
13.45%
Net profit margin
3.68%
Promoter holding
37.89%
Sales (last year)
₹913 Cr

Guidance scorecard · Q2 FY27 call

What Valiant Organics's management guided
and where it ranks in Chemicals & Petrochemicals

RevenueQ3 FY24 call

40%+
  • FY25 revenue expected in the range of INR 900-1000 crores, with conservative estimates due to current market conditions.
  • Growth of approximately 40% anticipated in FY25 driven by volume improvement in PAP and new Pharma Intermediates and chlorophenol products.
  • Incremental revenue of around INR 200 crores expected from PAP at full capacity (~600-700 tons/month targeted by year-end).
  • Pharma Intermediates expected to contribute approximately INR 70-80 crores, with launch of eight new products planned early FY25.
  • OAP products likely to add INR 20-30 crores.
  • Capacity expansions have increased overall production capabilities significantly since 2020, with about 2000 MT added annually excluding PAP.

2 more points from Valiant Organics's call on revenue

Create a free account to keep reading this call

Full Q3 FY24 analysis

MarginsQ3 FY24 call

Up 2%+

See what Valiant Organics said on margins — free account, 30 seconds.

Full Q3 FY24 analysis

CapexQ3 FY24 call

None planned
  • For FY25, Valiant Organics does not plan any large or significant CapEx, only standard maintenance CapEx of around INR 30-40 crores.
  • Any major CapEx decisions will be considered based on how the current year unfolds, potentially planned in the second half of the year for subsequent years.
  • No immediate major capital investment is planned until market conditions stabilize, especially given the current pricing pressures.

2 more points from Valiant Organics's call on capex

Create a free account to keep reading this call

Full Q3 FY24 analysis

FundraisingQ3 FY24 call

See what Valiant Organics said on fundraising — free account, 30 seconds.

Full Q3 FY24 analysis

Order bookQ3 FY24 call

  • There has been subdued demand and pressure on pricing due to global slowdown and China dumping.
  • PAP (Paracetamol) sales averaged 119 MT per month initially, with a surge to 370 MT in December, indicating improving demand.
  • Management expects FY25 to be significantly better due to volume growth in PAP and new Pharma Intermediate projects.

2 more points from Valiant Organics's call on the order book

Create a free account to keep reading this call

Full Q3 FY24 analysis

Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.

Potential multibaggers · Q2 FY27

Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance

  1. Strong growth
    2
  2. 1
  3. Strong growth
    3

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Valiant Organics latest results (Sep 2026)

Revenue

₹304 Cr

+93% YoY

Net profit

₹17 Cr

+183% YoY

Operating margin

13%

EPS

₹6.17

What management said on the call →

Valiant Organics shareholding (Sep 2026)

Promoters

37.89%

+0.02 pp QoQ

FIIs

0.44%

+0.23 pp QoQ

DIIs

0.03%

+0.03 pp QoQ

Public

61.65%

−0.28 pp QoQ

Peers

Chemicals & Petrochemicals companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 2%+₹1,778 Cr19.8
240%+Up 0–2%₹262 Cr3.4
340%+Flat₹8,439 Cr208.8
440%+Flat₹2,302 Cr26.3
540%+Flat₹179 Cr11.8
640%+Flat₹154 Cr16.9

Financials of Valiant Organics

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Shareholder Pattern

Valiant Organics

Shareholding breakup across reporting periods.

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters +37.90%37.77%37.77%37.77%37.73%37.91%37.91%37.91%37.89%37.89%37.87%37.89%
FIIs +0.69%1.14%1.35%1.34%0.82%0.37%0.21%0.21%0.22%0.28%0.21%0.44%
DIIs +0.87%0.43%0.09%0.08%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.03%
Public +60.54%60.65%60.79%60.80%61.44%61.72%61.87%61.86%61.89%61.82%61.93%61.65%
No. of Shareholders49,05050,46050,02248,18949,01748,07744,29343,27442,31140,92840,52637,909

Financials of Valiant Organics

Quarterly Results

Quarter-by-quarter operating performance

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales +203141177168160187204204157159218232304
YoY Sales growth-23%-44%-35%-17%-21%+32%+15%+22%-2%-15%+7%+13%+93%
Expenses +188139179152159172183180136146191190265
Operating Profit153-21611521252113264239
OPM %8%1.8%-1.2%9%0.5%8%10%12%13%8%12%18%13%
Other Income +40-703612075111
Interest4475865645355
Depreciation999999991010101010
Profit before tax6-10-252-14671176183725
Tax %26%-20%-20%128%-9%14%43%26%24%38%10%20%30%
Net Profit +5-8-20-1-1254864162917
EPS in Rs1.58-2.86-7.32-0.22-4.631.981.502.932.021.305.6110.366.17

Financials of Valiant Organics

Profit & Loss

Annual income statement trend

Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales +6926757551,1531,052723719739913
Sales growth-2%+12%+53%-9%-31%-1%+3%+21%
Expenses +511494549948888686665652792
Operating Profit181181205205164375387120
OPM %26%27%27%18%16%5%7%12%13%
Other Income +866713691324
Interest43561116241818
Depreciation141621302935364041
Profit before tax171168185176137-924285
Tax %29%25%29%27%25%-3%260%21%
Net Profit +121126131128103-8-33366
EPS in Rs103.6551.0042.1941.7232.45-3.04-1.3411.8623.44
Dividend Payout %6%11%12%8%3%0%0%0%

Financials of Valiant Organics

Balance Sheet

Capital structure and asset base

Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital61227272728282828
Reserves254374475586662702697731778
Borrowings +77140209364274257249256259
Other Liabilities +112143165216276262209217270
Total Liabilities4486698761,1921,2391,2481,1831,2321,335
Fixed Assets +150276510543670643657695678
CWIP66129461127186662141
Investments122368419994151140
Other Assets +221241314529457420367365477
Total Assets4486698761,1921,2391,2481,1831,2321,335

Financials of Valiant Organics

Cash Flows

Operating, investing and financing cash movement

Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +76161113-31238845692
Cash from Investing Activity +-86-184-156-124-143-65-21-86
Cash from Financing Activity +12749167-112-23-32-11
Net Cash Flow-95512-17-44-5
Free Cash Flow-13-44-58-153108192759
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit68%112%78%6%162%238%106%103%

Financials of Valiant Organics

Ratios

Working capital efficiency and return ratios

Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days7572761028810690120
Inventory Days4442635468887177
Days Payable6982936389159119102
Cash Conversion Cycle5032459367344296
Working Capital Days4620-12111-3-100
ROCE %39%30%21%14%1%3%5%

Guidance history

How Valiant Organics's guidance has moved, call by call

CallRevenueMarginsCapexFundraisingOrder book
Q3 FY24 call →40%+Up 2%+None planned——
Q2 FY24 call →10–20%Down 0–2%PlannedPlanned—
Q1 FY24 call →DeclineFlatPlannedPlanned—
Q4 FY23 call →20–40%FlatPlannedPlanned—

What management guided on each call, newest first. Not investment advice, and not a forecast of returns.

36out of 100

Momentum score · price trend

36 out of 100 — Cooling

Over the past year its share price has done worse than most of the stocks we track.

PeriodShare price changeBetter than … of 1,947 stocks
Last 12 months+19.7%70%
Last 6 months+15.5%67%
Last 3 months+12.5%82%

The price is 81.1% below its all-time high of ₹1,844.95 (6 Nov 2020). Stocks more than 20% below their peak have their score halved, so 71 became 36.

How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,947 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Valiant Organics: 0.4 × 70 + 0.4 × 67 + 0.2 × 82 = 71, halved to 36 because the price is more than 20% below its all-time high.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 17 Nov 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

Valiant Organics: frequently asked questions

What is Valiant Organics share price today?

Valiant Organics last traded at ₹348.2, with a market capitalisation of ₹976 Cr and a P/E ratio of 17.5.

What were Valiant Organics's latest quarterly results?

For the quarter ended Sep 2026, Valiant Organics reported revenue of ₹304 Cr (+93% year on year) and net profit of ₹17 Cr, with an operating margin of 13%.

Is Valiant Organics's profit growing?

Net profit was ₹17 Cr in Sep 2026 against ₹6 Cr in Sep 2025, a change of +183%.

What is Valiant Organics's EPS?

Valiant Organics's earnings per share for the quarter ended Sep 2026 was ₹6.17.

What is the promoter holding in Valiant Organics?

Promoters held 37.89% of Valiant Organics in Sep 2026 (+0.02 pp versus Jun 2026).

How much do FIIs and DIIs hold in Valiant Organics?

In Sep 2026, foreign institutional investors held 0.44% and domestic institutions (including mutual funds) held 0.03% of Valiant Organics.

What is Valiant Organics's ROE and ROCE?

Valiant Organics's return on equity is 3.5% and its return on capital employed is 5.47%.

Does Valiant Organics pay a dividend?

Valiant Organics's dividend yield is 0% at the current price; see the Valiant Organics dividends page for past payouts.

Which sector does Valiant Organics belong to?

Valiant Organics is in the Chemicals & Petrochemicals sector. Its peer comparison and sector ranking are on this page.

What did Valiant Organics's management say on the latest earnings call?

Arthneeti's analysis of the Q2 FY27 earnings call covers revenue, margins, capex and fundraising guidance from Valiant Organics's management.

How does Arthneeti AI analyse Valiant Organics?

Arthneeti reads Valiant Organics's earnings call transcripts and filings and scores revenue growth, margins, capex and fundraising, then ranks the company against its sector.

Others in Chemicals & Petrochemicals this season

  • Seya Industries (Q2 FY27)

    Revenue from Operations (Net) for the quarter ended September 30, 2026: ₹0 lakhs (no sales reported). Key results statement takeaways from Seya Industries Ltd's

  • DCM Shriram Fine Chemicals (Q2 FY27)

    9,622.39 lakhs for the quarter ended September 30, 2025, indicating a year-on-year decrease of approximately 7.8%. Key results statement takeaways from DCM Shri

  • Dhariwalcorp (Q2 FY27)

    For the half year ended September 30, 2026, consolidated revenue from operations is ₹23,640.36 lakhs, up from ₹17,767.97 lakhs in the previous comparable…

  • Agastya Energy (Q2 FY27)

    For the quarter ended 30th September 2026, the consolidated revenue from operations was ₹625.15 lakhs, down from ₹4410.2 lakhs in the same quarter last year…